SO
PRLD icon

STRS Ohio’s Prelude Therapeutics PRLD Stock Holding History

STRS Ohio’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3K Buy
+5,500
New +$23.9K ﹤0.01% 2095
2022
Q2 		– Sell
-2,200
Closed -$15K – 2229
2022
Q1 		$15K Hold
2,200
– – ﹤0.01% 2067
2021
Q4 		$27K Hold
2,200
– – ﹤0.01% 2082
2021
Q3 		$68K Hold
2,200
– – ﹤0.01% 2014
2021
Q2 		$62K Hold
2,200
– – ﹤0.01% 2071
2021
Q1 		$95K Hold
2,200
– – ﹤0.01% 1955
2020
Q4 		$157K Buy
+2,200
New +$109K ﹤0.01% 1801

Other funds holding PRLD

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

STRS Ohio's PRLD Position: Q2 2026 in Review

STRS Ohio opened a new position in Prelude Therapeutics (PRLD) in Q2 2026: 5,500 shares worth $29.3K. The stake represents ﹤0.01% of the portfolio and ranks #2095 among its holdings. This is a return to the name: STRS Ohio previously reported a position in PRLD as recently as Q1 2022.

STRS Ohio first reported a position in PRLD in Q4 2020 and has held it in 7 quarters since. The position peaked at $157K in Q4 2020. 75 funds tracked by Wall St. Rank hold PRLD as of Q2 2026.

  • STRS Ohio held 5,500 shares of Prelude Therapeutics worth $29.3K as of Q2 2026.
  • Prelude Therapeutics was a new STRS Ohio position in Q2 2026.
  • Prelude Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2095 holding.
  • STRS Ohio first reported a position in Prelude Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • STRS Ohio's Prelude Therapeutics position peaked at $157K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.